Canton Hathaway’s iShares Biotechnology ETF IBB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.68M	Hold	9,961	–	–	0.34%	44
2025 Q4	$1.68M	Hold	9,961	–	–	0.32%	38
2025 Q3	$1.44M	Hold	9,961	–	–	0.28%	47
2025 Q2	$1.26M	Sell	9,961 -4,500	-31%	-$552K	0.26%	47
2025 Q1	$1.85M	Buy	14,461 +4,500	+45%	+$610K	0.37%	32
2024 Q4	$1.32M	Buy	9,961 +100	+1%	+$14.1K	0.33%	39
2024 Q3	$1.44M	Sell	9,861 -190	-2%	-$27.5K	0.36%	35
2024 Q2	$1.38M	Hold	10,051	–	–	0.38%	37
2024 Q1	$1.38M	Hold	10,051	–	–	0.37%	36
2023 Q4	$1.36M	Sell	10,051 -1,200	-11%	-$146K	0.41%	31
2023 Q3	$1.38M	Hold	11,251	–	–	0.44%	31
2023 Q2	$1.43M	Sell	11,251 -1,600	-12%	-$208K	0.45%	32
2023 Q1	$1.66M	Buy	12,851 +8	+0.1%	+$1.05K	0.57%	27
2022 Q4	$1.69M	Sell	12,843 -2,130	-14%	-$275K	0.59%	25
2022 Q3	$1.75M	Buy	14,973 +435	+3%	+$54K	0.64%	25
2022 Q2	$1.71M	Hold	14,538	–	–	0.6%	28
2022 Q1	$1.89M	Sell	14,538 -2,588	-15%	-$337K	0.53%	32
2021 Q4	$2.61M	Buy	17,126 +210	+1%	+$32.5K	0.71%	26
2021 Q3	$2.73M	Buy	16,916 +1,672	+11%	+$281K	0.79%	23
2021 Q2	$2.5M	Buy	15,244 +773	+5%	+$119K	0.73%	27
2021 Q1	$2.18M	Buy	14,471 +597	+4%	+$94.8K	0.7%	26
2020 Q4	$2.1M	Buy	13,874 +6,568	+90%	+$939K	0.71%	26
2020 Q3	$989K	Buy	7,306 +4,016	+122%	+$545K	0.41%	35
2020 Q2	$450K	Buy	3,290 +418	+15%	+$53.3K	0.29%	41
2020 Q1	$309K	Buy	2,872 +625	+28%	+$72K	0.22%	48
2019 Q4	$271K	Hold	2,247	–	–	0.14%	73
2019 Q3	$224K	Hold	2,247	–	–	0.12%	77
2019 Q2	$245K	Buy	2,247 +500	+29%	+$53.2K	0.14%	73
2019 Q1	$195K	Hold	1,747	–	–	0.11%	74
2018 Q4	$168K	Buy	1,747 +1,192	+215%	+$127K	0.11%	66
2018 Q3	$68K	Buy	+555	New	+$65.4K	0.04%	89